Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3 Sarcoma 2 Other hematologic neoplasm 2 Genitourinary 2 Thoracic 1 Plasma cell 1 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 Breast 1

Conditions

Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 1413 Fluorouracil 1301 Capecitabine 1087 Gemcitabine 1045 Leucovorin 932 Irinotecan 818 Bevacizumab 804 Cisplatin 669 Radiotherapy 536 Cetuximab 470 pembrolizumab 428 Paclitaxel 390 Nivolumab 337 130-nm albumin-bound paclitaxel 325 Drug Therapy 314 Docetaxel 287 S 1 (combination) 274 Sorafenib 266 Folfox protocol 261 Albumin-Bound Paclitaxel 259 sintilimab 211 durvalumab 210 Surgical Procedures, Operative 204 tislelizumab 203 Radiosurgery 202 lenvatinib 201 apatinib 200 Carboplatin 187 Magnetic Resonance Spectroscopy 183 regorafenib 181

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lithium Carbonate × Gastrointestinal × Clear all

NCT05402891 2024-10-04

Lithium in FAP

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡